Literature DB >> 27629384

Combined variants in factor VIII and prostaglandin synthase-1 amplify hemorrhage severity across three generations of descendants.

D Nance1, R A Campbell2, J W Rowley2,3, J M Downie4, L B Jorde4, W H Kahr5,6,7, S A Mereby2, N D Tolley2, G A Zimmerman3, A S Weyrich2,3, M T Rondina2,3,8.   

Abstract

Essentials Co-existent damaging variants are likely to cause more severe bleeding and may go undiagnosed. We determined pathogenic variants in a three-generational pedigree with excessive bleeding. Bleeding occurred with concurrent variants in prostaglandin synthase-1 (PTGS-1) and factor VIII. The PTGS-1 variant was associated with functional defects in the arachidonic acid pathway.
SUMMARY: Background Inherited human variants that concurrently cause disorders of primary hemostasis and coagulation are uncommon. Nevertheless, rare cases of co-existent damaging variants are likely to cause more severe bleeding and may go undiagnosed. Objective We prospectively sought to determine pathogenic variants in a three-generational pedigree with excessive bleeding. Patients/methods Platelet number, size and light transmission aggregometry to multiple agonists were evaluated in pedigree members. Transmission electron microscopy determined platelet morphology and granule content. Thromboxane release studies and light transmission aggregometry in the presence or absence of prostaglandin G2 assessed specific functional defects in the arachidonic acid pathway. Whole exome sequencing (WES) and targeted nucleotide sequence analysis identified potentially deleterious variants. Results Pedigree members with excessive bleeding had impaired platelet aggregation with arachidonic acid, epinephrine and low-dose ADP, as well as reduced platelet thromboxane B2 release. Impaired platelet aggregation in response to 2MesADP was rescued with prostaglandin G2 , a prostaglandin intermediate downstream of prostaglandin synthase-1 (PTGS-1) that aids in the production of thromboxane. WES identified a non-synonymous variant in the signal peptide of PTGS-1 (rs3842787; c.50C>T; p.Pro17Leu) that completely co-segregated with disease phenotype. A variant in the F8 gene causing hemophilia A (rs28935203; c.5096A>T; p.Y1699F) was also identified. Individuals with both variants had more severe bleeding manifestations than characteristic of mild hemophilia A alone. Conclusion We provide the first report of co-existing variants in both F8 and PTGS-1 genes in a three-generation pedigree. The PTGS-1 variant was associated with specific functional defects in the arachidonic acid pathway and more severe hemorrhage.
© 2016 International Society on Thrombosis and Haemostasis.

Entities:  

Keywords:  DNA sequencing; bleeding; blood platelet disorder; hemophilia A; platelet aggregation

Mesh:

Substances:

Year:  2016        PMID: 27629384      PMCID: PMC5501291          DOI: 10.1111/jth.13500

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  34 in total

1.  Identification of deleterious mutations within three human genomes.

Authors:  Sung Chun; Justin C Fay
Journal:  Genome Res       Date:  2009-07-14       Impact factor: 9.043

2.  Comparison and integration of deleteriousness prediction methods for nonsynonymous SNVs in whole exome sequencing studies.

Authors:  Chengliang Dong; Peng Wei; Xueqiu Jian; Richard Gibbs; Eric Boerwinkle; Kai Wang; Xiaoming Liu
Journal:  Hum Mol Genet       Date:  2014-12-30       Impact factor: 6.150

3.  From FastQ data to high confidence variant calls: the Genome Analysis Toolkit best practices pipeline.

Authors:  Geraldine A Van der Auwera; Mauricio O Carneiro; Christopher Hartl; Ryan Poplin; Guillermo Del Angel; Ami Levy-Moonshine; Tadeusz Jordan; Khalid Shakir; David Roazen; Joel Thibault; Eric Banks; Kiran V Garimella; David Altshuler; Stacey Gabriel; Mark A DePristo
Journal:  Curr Protoc Bioinformatics       Date:  2013

4.  The septic milieu triggers expression of spliced tissue factor mRNA in human platelets.

Authors:  M T Rondina; H Schwertz; E S Harris; B F Kraemer; R A Campbell; N Mackman; C K Grissom; A S Weyrich; G A Zimmerman
Journal:  J Thromb Haemost       Date:  2011-04       Impact factor: 5.824

5.  Identification and functional characterization of polymorphisms in human cyclooxygenase-1 (PTGS1).

Authors:  Craig R Lee; Frank G Bottone; Joseph M Krahn; Leping Li; Harvey W Mohrenweiser; Molly E Cook; Robert M Petrovich; Douglas A Bell; Thomas E Eling; Darryl C Zeldin
Journal:  Pharmacogenet Genomics       Date:  2007-02       Impact factor: 2.089

6.  Cyclooxygenase-1 haplotype C50T/A-842G does not affect platelet response to aspirin.

Authors:  Caterina Pettinella; Mario Romano; Liborio Stuppia; Francesca Santilli; Rossella Liani; Giovanni Davì
Journal:  Thromb Haemost       Date:  2009-04       Impact factor: 5.249

7.  Molecular characterization of severe hemophilia A suggests that about half the mutations are not within the coding regions and splice junctions of the factor VIII gene.

Authors:  M Higuchi; H H Kazazian; L Kasch; T C Warren; M J McGinniss; J A Phillips; C Kasper; R Janco; S E Antonarakis
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

8.  dbNSFP v2.0: a database of human non-synonymous SNVs and their functional predictions and annotations.

Authors:  Xiaoming Liu; Xueqiu Jian; Eric Boerwinkle
Journal:  Hum Mutat       Date:  2013-07-10       Impact factor: 4.878

9.  An integrated map of genetic variation from 1,092 human genomes.

Authors:  Goncalo R Abecasis; Adam Auton; Lisa D Brooks; Mark A DePristo; Richard M Durbin; Robert E Handsaker; Hyun Min Kang; Gabor T Marth; Gil A McVean
Journal:  Nature       Date:  2012-11-01       Impact factor: 49.962

10.  Predicting the functional, molecular, and phenotypic consequences of amino acid substitutions using hidden Markov models.

Authors:  Hashem A Shihab; Julian Gough; David N Cooper; Peter D Stenson; Gary L A Barker; Keith J Edwards; Ian N M Day; Tom R Gaunt
Journal:  Hum Mutat       Date:  2012-11-02       Impact factor: 4.878

View more
  2 in total

1.  Effect of aspirin response signature gene expression on preterm birth and preeclampsia among women with lupus: a pilot study.

Authors:  A M Eudy; D Voora; R A Myers; M E B Clowse
Journal:  Lupus       Date:  2019-11-04       Impact factor: 2.911

2.  Identification of a homozygous recessive variant in PTGS1 resulting in a congenital aspirin-like defect in platelet function.

Authors:  Melissa V Chan; Melissa A Hayman; Suthesh Sivapalaratnam; Marilena Crescente; Harriet E Allan; Matthew L Edin; Darryl C Zeldin; Ginger L Milne; Jonathan Stephens; Daniel Greene; Moghees Hanif; Valerie B O'Donnell; Liang Dong; Michael G Malkowski; Claire Lentaigne; Katherine Wedderburn; Matthew Stubbs; Kate Downes; Willem H Ouwehand; Ernest Turro; Nihr BioResource; Daniel P Hart; Kathleen Freson; Michael A Laffan; Timothy D Warner
Journal:  Haematologica       Date:  2021-05-01       Impact factor: 9.941

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.